학술논문

The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial
Document Type
Article
Source
In Annals of Oncology November 2018 29(11):2240-2246
Subject
Language
ISSN
0923-7534